Formation of the three-dimensional structure of the heart begins with fusion of bilateral mesodermal planes that subsequently differentiate into beating cardiomyocytes[@b1][@b2]. Initially, the cardiomyocytes contract randomly but they soon become synchronized as the heart tube develops. Subsequently, the contractions are coordinated into rhythmic waves along the heart tube generating unidirectional blood flow. In the early valveless stages, one-way flow is generated by a hydroelastic suction pump[@b3]. Later, an S-shaped bend forms in the tube and the cardiomyocytes proliferate causing bulges, which develop into two distinct chambers, the atrium and ventricle, with constrictions in the outflow tract (OFT) and atrioventricular (AV) canal. Valves develop at these strictures to ensure unidirectional circulation. Throughout these morphogenetic events, blood flow is maintained. As the valves form at constrictions, the valve-forming endocardial cells are subject to higher sheer forces.

Many studies have suggested that haemodynamic stresses provide essential morphogenetic cues for normal cardiogenesis. Perturbation of blood flow by beads in zebrafish heart causes morphological defects like those observed in congenital heart diseases[@b4][@b5]. Auman *et al.*[@b6] reported that the blood flow and contractility regulate the shape of cardiomyocytes and the form of the heart. More recently, reversing blood flow has been shown to regulate valvulogenesis via expression of *krüppel-like factor 2a* (*klf2a*) (ref. [@b7]), highlighting a putative link between gene expression and mechanical stimuli.

MicroRNAs (miRNAs) are small non-coding RNAs. Primary transcripts of miRNAs are processed by Drosha and Dicer and the products are incorporated into the RNA-induced silencing complex[@b8]. Target mRNAs are degraded or repressed at the translational level, bypassing the transcriptional control of mRNA[@b9]. We speculated that this rapid regulation might be active during cardiogenesis to couple morphogenesis with haemodynamic changes. This idea is further supported by reports that several miRNAs are induced in mouse hearts subjected to pressure overload[@b10] and in mechanically stretched smooth muscle[@b11]. Moreover, recent studies have suggested that miRNAs contribute to haemodynamically dependent cardiogenesis[@b12] and angiogenesis[@b13].

*miR-21* is highly expressed in malignant tissues and has several target genes, including *PDCD4*, *PTEN* and *SPRY2*. These genes exhibit a tumour-suppressing effect, classifying it as an oncomiR[@b14]. Accordingly, deletion of mouse *miR-21* suppresses lung tumorigenesis by modulating the Ras/MEK/ERK pathway and apoptosis[@b15].

*miR-21* is also expressed during cardiac remodelling and appears to be functional in cardiovascular diseases[@b16]. However, stress-induced cardiac remodelling occurs in the absence of *miR-21* in the mouse[@b17]. In this report, we provide evidence that *miR-21* functions differently in zebrafish. By sensing blood flow, it regulates heartbeat-dependent valvulogenesis by repression of the same target genes as in the mouse. We conclude that *miR-21* is a crucial component of the programme that regulates valve formation in the zebrafish heart, using haemodynamic stimuli as a physical morphogen.

Results
=======

Expression patterns of zebrafish *miR-21*
-----------------------------------------

In zebrafish, valvulogenesis is initiated between 24 and 48 h post-fertilization (hpf) at the AV canal[@b18]. Within the canal, the pulsatile flow has critical roles for multiple morphogenetic events, including cell shape changes, protrusion of valve leaflets and expression of *klf2a* (ref. [@b7]). Expression of *miR-21* started at 36 hpf in a small subset of the endocardial cells at the AV constriction ([Fig. 1a](#f1){ref-type="fig"}). At 48 hpf, this expression became stronger with an additional endocardial spot in the OFT ([Fig. 1b](#f1){ref-type="fig"}). These two domains became evident at 72 hpf. The expression patch in the AV canal developed a hole at the centre corresponding to the lumen, while the OFT expression exhibited a streak parallel to the blood flow ([Fig. 1c](#f1){ref-type="fig"}). *miR-21* expression in the AV canal was restricted to the endocardial cells and was not observed in the myocardium ([Fig. 1d](#f1){ref-type="fig"}). As cardiogenesis proceeded, similar expression patterns were observed at 120 hpf ([Fig. 1e](#f1){ref-type="fig"}), and even in the valves of more than 1-year-old adult fishes ([Fig. 1f](#f1){ref-type="fig"}). The expression patterns are summarized in [Fig. 1h](#f1){ref-type="fig"}.

Haemodynamically dependent expression of zebrafish *miR-21*
-----------------------------------------------------------

The presence of *miR-21* expression at constricted sections of the endocardium suggested that it might be influenced by the blood flow. To investigate this, heartbeat was stopped by injecting a morpholino antisense oligonucleotide (MO) against *troponin T2* (*tnnt2*) (refs [@b18], [@b19]). In this morphant, expression of *miR-21* was not observed at either 48 or 72 hpf ([Fig. 2b](#f2){ref-type="fig"}), whereas beating hearts showed distinct two expression spots ([Fig. 2a](#f2){ref-type="fig"}).

*Silent heart* mutants (*sih*), in which *tnnt2* is mutated, exhibit morphological defects in their hearts. To exclude the possibility that the loss of the *miR-21* expression in the *tnnt2* morphants was a secondary effect of those abnormalities, we stopped the heartbeat temporarily and reversibly using 2,3-butanedione monoxime (BDM, a myosin ATPase inhibitor)[@b20]. When the heartbeat was arrested for 12 h, from 72 to 84 hpf, expression of *miR-21* was suppressed at 84 hpf (in 21 of 32 fish, [Fig. 2e](#f2){ref-type="fig"}). Similarly, when the heartbeat was stopped from 60 to 72 hpf, expression was lost at 72 hpf (in 18 of 30 fish, [Fig. 2f](#f2){ref-type="fig"}). These data indicate that arrest of the heartbeat for 12 h is sufficient to cancel expression of *miR-21*. Conversely, when the heartbeat was reinitiated by washing out the BDM at 72 hpf, *miR-21* expression was reestablished at 73 hpf at both valve-forming regions (in 35 of 39 fish, [Fig. 2g](#f2){ref-type="fig"}). Thus, beating for 1 h can restore the full expression.

Biogenesis of mature miRNAs is regulated at multiple steps from transcription of primary miRNAs to the RNA-induced silencing complex-mediated targeting to mRNAs[@b21]. To check a transcriptional control of *miR-21*, we made a probe that specifically recognizes *pri-miR-21-1*, one of two primary transcripts of zebrafish *miR-21* on two different chromosomal loci. At 72 hpf, this probe localized at the same positions ([Fig. 2h](#f2){ref-type="fig"}). In sections, expression of *pri-miR-21-1* was observed in the valve-forming endocardial cells ([Fig. 2i](#f2){ref-type="fig"}). It was absent in the *tnnt2* morphants at 72 hpf ([Fig. 2j](#f2){ref-type="fig"}). Similarly, 12 h of arrest cancelled the expression at 84 and 72 hpf (13 of 24 and 15 of 30 fishes, respectively, [Fig. 2k](#f2){ref-type="fig"}), and 1 h of heartbeat restored it (37 of 42 fishes, [Fig. 2m](#f2){ref-type="fig"}). These data indicate that transcription of *pri-miR-21* is regulated in a heartbeat-dependent manner and that the transcriptional response to heart beating is very fast.

It has been shown that the valve formation is dependent on the retrograde flow, rather than blood viscosity, as verified in *gata1* and *gata2* morphants[@b7]. The *gata1* morphants lack circulating blood cells[@b22], hence have lower blood viscosity, whereas the *gata2* morphants have reduced retrograde flow at the AV canal[@b7], due to abnormal vascular development[@b23]. Valve formation was selectively impaired in the *gata2* morphants with a loss of *klf2a* expression. In accordance, expression of *miR-21* was lost in the *gata2* morphants, not in the *gata1* (see [Supplementary Fig. S1](#S1){ref-type="supplementary-material"}), supporting the importance of the reversing flow. In addition, injection of MO against neither *klf2a* nor *tbx2b* abrogated the expression of *miR-21*. This suggests independence of the *miR-21* expression from klf2a or the AV boundary formation in the myocardium[@b24] (see [Supplementary Fig. S1](#S1){ref-type="supplementary-material"}).

In an opposite approach, we bathed embryos in water containing 2 mM epinephrine at 51.5 hpf for 1.5 h to elevate the heart rate along with vasoconstriction. This stimulation should increase the mechanical stress to the valve-forming endocardial cells and the vascular endothelium in the periphery. After the stimulation, the expression of *pri-miR-21-1* in the valve was slightly intensified ([Fig. 3b](#f3){ref-type="fig"}), relative to the normal expression ([Fig. 3a](#f3){ref-type="fig"}). In the *tnnt2* morphants, the expression was repressed, even in the presence of epinephrine ([Fig. 3e](#f3){ref-type="fig"}). Next, we injected MO against *gata1*, which eliminated blood cells[@b22] and lowered the viscosity[@b7]. The expression of *pri-miR-21-1* was not affected ([Fig. 3c](#f3){ref-type="fig"}) and, in the stimulated heart, this expression was enhanced ([Fig. 3d](#f3){ref-type="fig"}).

Although the endothelial cells in the head do not express *pri-miR-21-1* ([Fig. 3f](#f3){ref-type="fig"}), they exhibited strong expression after the epinephrine treatment ([Fig. 3g](#f3){ref-type="fig"}). This induction was not cancelled by injection of the *gata1* MO ([Fig. 3i](#f3){ref-type="fig"}). In the *tnnt2* morphants, *pri-miR-21-1* was not expressed in the head, even after the epinephrine stimulation ([Fig. 3j](#f3){ref-type="fig"}). Injection of the *gata1* MO alone did not induce *pri-miR-21-1* ([Fig. 3h](#f3){ref-type="fig"}).

To confirm further, we semi-quantitated the expression of *miR-21* by quantitative real-time PCR (qRT--PCR) on RNA isolated from the whole bodies ([Fig. 3k](#f3){ref-type="fig"}). The epinephrine treatment induced *miR-21* \~1.7-fold in the WT and 1.4-fold in the *gata1* MO. As expected, this induction was cancelled in the *tnnt2*.

Haemodynamic parameters were measured in the middle cerebral vein before and after the adrenergic stimulation (see [Supplementary Fig. S2](#S1){ref-type="supplementary-material"}). The shear stress was estimated to be increased 2.1-fold by epinephrine.

Physical regulation of *miR-21* expression was confirmed using cultured mammalian cells (see [Supplementary Fig. S2](#S1){ref-type="supplementary-material"}). Application of 2.0 Pa of shear stress (equivalent to that at the luminal surface of the human aorta[@b25]) with a unidirectional laminar flow over human umbilical vein endothelial cells (HUVECs) rapidly induced expression of mature *miR-21*. The primary *miR-21* transcript was induced more strongly. *KLF2* was induced rapidly within 15 min, and the expression increased progressively, hitting the highest peak after 2 h. These results indicate that a set of genes can be induced by the shear stress, but with different temporal profiles.

We have found another valve-specific gene, *egr1*, which expression is dependent on the heartbeat (see [Supplementary Fig. S2](#S1){ref-type="supplementary-material"}). Previously, we have reported that myocardial expression of *miR-143* in the OFT is dependent on the heartbeat[@b12]. Nonetheless, induction of *miR-143* by mechanical stresses is slower. This suggests that the adaptive responses triggered by the mechanical stimuli are temporally controlled. Laminar flow has been shown to induce other genes in HUVECs (including *Klf2, COX-2*, *ICAM-1* and *c-fos*)[@b26][@b27], but the response of *miR-21* is the fastest.

In addition to the temporal control, cells react differentially to different flows, such as laminar versus turbulent flows and unidirectional versus reciprocating ones[@b28]. *pri-miR-21* was induced more rapidly when reciprocating flow at 0.5 Hz was applied, although induction of mature *miR-21* was kept weak (see [Supplementary Fig. S2](#S1){ref-type="supplementary-material"}). In this condition, *Klf2* was also induced faster, but weakly than the unidirectional flow. Induction of *pri-miR-21* was sustained longer. 1.0 Hz reciprocating flow exerted the similar effect, but induction of *pri-miR-21*was more robust. Interestingly, induction of mature *miR-21* was very weak in HUVECs stimulated by the reciprocating flow. This suggests that processing of *pri-miR-21* might be repressed by this flow. This also implies that the actions of *miR-21* might be repressed even after stimulation by specific shear stress, consistent with the fact that genetic deletion of *miR-21* does not affect the correct formation of vasculature and heart[@b15].

A valveless phenotype of *miR-21* morphants
-------------------------------------------

To explore the roles of *miR-21*, we injected MOs of several designs against *miR-21* at the one-cell stage ([Fig. 4](#f4){ref-type="fig"}) (see Methods). For this experiment, we designed two types of MOs, one for multiblocking that disturbs both Dicer and Drosha-mediated processing and another for Guide Dicer that masks guide sequence to block processing *miR-21-1* and *miR-21-2* by Dicer. These MOs gave similar results. Co-injection of both *miR-21-1* and *miR-21-2* MOs knocked down *miR-21* more efficiently. The expression of *miR-21* in the morphants was reduced to one-third of that in the WT (see [Supplementary Fig. S3](#S1){ref-type="supplementary-material"}). Scrambled MO did not induce obvious abnormalities ([Fig. 4b](#f4){ref-type="fig"}). At 48 hpf, blood pooled on the surface of the yolk in the morphants indicating stagnation of flow ([Fig. 4c](#f4){ref-type="fig"}). The hearts of the morphants are narrower, showing incomplete looping (Fig. 4g,h). Other parts of body were normal, except for slight hypoplasia of the hindbrain, where *miR-21* was weakly expressed.

In sections, the clustering and thickening of the valve-forming cells, visualized by *fli1:GFP*[@b29] and Dm-grasp staining[@b30], were absent in the morphants at 72 hpf ([Fig. 4n--r](#f4){ref-type="fig"}), whereas those are obvious in the WT ([Fig. 4i--m](#f4){ref-type="fig"}). These changes were also lost in the hearts arrested from 24 to 72 hpf by BDM ([Fig. 4s--w](#f4){ref-type="fig"}). Although the similar abnormalities in the endocardium were evident at 55 hpf, myocardial cell shape change in the AV canal occurred normally in the morphants. (see [Supplementary Fig. S4](#S1){ref-type="supplementary-material"}). Further verification was provided by rescue experiments using *miR-21* duplex (see [Supplementary Fig. S3](#S1){ref-type="supplementary-material"}).

As there were fewer valve-forming cells in the morphants, we counted their numbers, and found significant reductions in both the *miR-21* morphants and the BDM-treated hearts, without affecting the myocardial cells (see [Supplementary Fig. S3](#S1){ref-type="supplementary-material"}). In addition, expression of proliferating cell nuclear antigen (PCNA)[@b31] was lost or weak in the valve-forming cells in the *miR-21* morphants and embryos treated with BDM (see [Supplementary Fig. S5](#S1){ref-type="supplementary-material"}).

We examined the expression of several markers. Specification of the atrial versus ventricular identity was not affected (see [Supplementary Fig. S3](#S1){ref-type="supplementary-material"}). In addition, expression of two myocardial markers was not affected by the *miR-21* MO, although expression of *versican* was expanded (see [Supplementary Fig. S6](#S1){ref-type="supplementary-material"}). Expression of two markers for the valve-forming endocardial cells, *hyaluronan synthase 2* (*has2*) and *notch1b*, was observed widely in both the atrial and the ventricular compartments (see [Supplementary Fig. S6](#S1){ref-type="supplementary-material"}). Flow-dependent expression of *egr1* was severely reduced[@b32], probably due to weak blood flow in the *miR-21* morphants (see [Supplementary Fig. S6](#S1){ref-type="supplementary-material"}). Expression of the *secreted phosphoprotein 1* (*spp1*), the endocardial marker at later stages of the valve development, was reduced, suggesting that maturation of valves was impaired. This decline might be partially due to the weak expression of *egr1*, as *Spp1* was reported to be a direct target of Egr1 in mouse and GC-rich Egr1-binding motifs are conserved in *spp1* (ref. [@b33]). As shown later, a loss of function of *miR-21* results in reduction of the mitogen-activated protein (MAP) kinase cascade. As the MAK kinase signals were shown to be involved in the expression of *Egr1* (ref. [@b34]), this pathway could modulate expression of *egr1* in zebrafish. Expression of *klf2a* was not affected.

*Sprouty 2* as a target of *miR-21*
-----------------------------------

As a member of the oncomiRs, *miR-21* has been analysed in mammals, and several targets identified[@b14][@b35]. *Sprouty2* (*spry2*), which encodes a potent inhibitor of the RTK/Ras/ERK pathway, is a direct target[@b36][@b37]. An exhaustive search of three databases (miRbase, RNAi web and BiBiServ) revealed no new targets but confirmed *spry2* in zebrafish. As shown in [Fig. 5a](#f5){ref-type="fig"}, the seed sequence of zebrafish *miR-21* shows significant paring at its 5′-end (see [Supplementary Fig. S7](#S1){ref-type="supplementary-material"}). To verify further, we synthesized two mRNAs. The first mRNA encoded enhanced green fluorescent protein (EGFP) with a 3′-untranslated region (UTR) of *spry2* and the other encoded mCherry fluorescent protein with a poly(A) signal alone. When these mRNAs were injected along with the *miR-21* MO, both green and red fluorescent signals were detected (left panel, [Fig. 5b](#f5){ref-type="fig"}). However, when a synthesized duplex of *miR-21* was co-injected, EGFP signals was selectively repressed (middle panel, [Fig. 5b](#f5){ref-type="fig"}), indicating that translation of EGFP was inhibited by the *miR-21* duplex. When the seed sequence in the 3′-UTR of *spry2* was mutated, EGFP signals were not repressed (right panel, [Fig. 5b](#f5){ref-type="fig"}).

These results are consistent with observations that although *spry2* is not normally expressed in the OFT and AV canal, it was induced in the *miR-21* morphants ([Fig. 5c](#f5){ref-type="fig"}), indicating that the regulatory action of *miR-21* is mediated at least by inhibition of s*pry2* and removal of suppression of the MAP kinase cascade. We also confirmed that expression of *programmed cell death 4a* (*pdcd4a*), *4b* (*pdcd4b*) and *phosphatase and tensin homologue B* (*ptenb*) were induced in the *miR-21* morphants ([Fig. 5d--f and h--j](#f5){ref-type="fig"}), consistent with mouse *miR-21* (refs [@b38], [@b39]). Hence, in both species, *miR-21* acts as a positive regulator of cell proliferation. Sequence alignments of the target regions are shown in [Supplementary Fig. S7](#S1){ref-type="supplementary-material"}. These results were further confirmed by qRT--PCR, using RNA isolated from whole bodies expressing *miR-21* as a transgene (see [Supplementary Fig. S7](#S1){ref-type="supplementary-material"}).

To confirm the roles of spry2 and the MAP kinase cascade, we injected a target protector MO against *spry2* (*spry2* target protection (TP) MO). Protection of *spry2* was confirmed (see [Supplementary Fig. S8](#S1){ref-type="supplementary-material"}). At 48 hpf, the *spry2* TP MO-injected embryos showed signs of pericardiac oedema and incomplete looping of the heart tube ([Fig. 6b](#f6){ref-type="fig"}). Next, we treated developing embryos with U0126, an inhibitor of the MAP kinase pathway to mimic the inhibitory effect of *spry2* (ref. [@b40]). U0126-treated embryos showed a cardiac phenotype similar to that of the *spry2* TP MO-injected embryos ([Fig. 6d](#f6){ref-type="fig"}) and *miR-21* morphants (*N*=92/145 for the *spry2* TP morphants and 56/92 for the U0126 treatment) ([Fig. 4](#f4){ref-type="fig"}).

Morphological alterations were confirmed by the green fluorescent protein (GFP) signals and Dm-grasp staining in *fli1:GFP* transgenic fishes at 72 hpf ([Fig. 6i--w](#f6){ref-type="fig"}). In both the *spry2*, TP MO-injected and U0126-treated embryos, the endocardial cells showed neither clustering nor thickening, with only a single layer of thin GFP-positive cells ([Fig. 6n--w](#f6){ref-type="fig"}). As revealed by Dm-grasp staining, only a few thin cells were visible at the AV canal ([Fig. 6p--r and u--w](#f6){ref-type="fig"}), whereas clustering of the multi-layered cuboidal cells was formed in the WT ([Fig. 6k--m](#f6){ref-type="fig"}). We also found that the endocardial cell number at the AV canal was decreased approximately by half in both the *spry2* TP MO-injected and U0126-treated embryos (see [Supplementary Fig. S8](#S1){ref-type="supplementary-material"}). In both the *spry2*, TP MO-injected and U0126-treated embryos, the myocardial expression of *versican* was expanded, whereas *bmp4* was unchanged. The endocardial expression of *notch1b* and *has2* became stronger. Expression of *spp1* was suppressed (see [Supplementary Fig. S9](#S1){ref-type="supplementary-material"}). PCNA staining was also suppressed (see [Supplementary Fig. S5](#S1){ref-type="supplementary-material"}).

Next, we examined MAP kinase signalling by staining a phosphorylated form of Erk1/2 at 55 hpf ([Fig. 7](#f7){ref-type="fig"}). In the WT, staining was evident in the cuboidal endocardial cells at the AV boundary ([Fig. 7a--c](#f7){ref-type="fig"}). In the *miR-21* morphants, staining was lost ([Fig. 7d--f](#f7){ref-type="fig"}). When heartbeat was arrested from 24 to 55 hpf by BDM, faint signals were detected only on the luminal surface ([Fig. 7g--i](#f7){ref-type="fig"}). Likewise, staining was significantly repressed in the *spry2* TP MO-injected and U0126-treated embryos ([Fig. 7j--o](#f7){ref-type="fig"}). These data indicate that the heartbeat, *miR-21*, *spry2* and MAP kinases are in the same signalling cascade.

Discussion
==========

Once contraction of cardiomyocytes commences, it continues for the entire lifetime. However, patterns of blood flow change along with transformation of the heart structures. Oxygen and nutritional demands change during development and with physiological and pathological conditions in adults so that cardiac tissues must change their structure and function accordingly. In both cardiogenesis and homoeostatic adaptation, cardiac tissues sense physical forces generated by the heartbeat and blood flow and respond with changes in gene expression. Thus, cardiac cells are mechanotransducers that convert physical inputs into biological outputs[@b41][@b42]. The molecular mechanisms of this signal conversion are largely unknown. Functional links between physical forces and gene expression are implied by the demonstration that the lineage of mesenchymal stem cells can be directed by matrix elasticity[@b43].

In the vascular system, shear stress induces *Klf2*. Knock-out of mouse *Klf2* results in a loss of the vascular integrity and subsequent haemorrhage, reinforcing the role of shear stress-dependent *Klf2* expression in the vascular homoeostasis[@b44]. In zebrafish, expression of *klf2a* in the AV canal is dependent on reversing blood flow. A loss of function of *klf2a*, which can be mimicked by arresting heartbeat or injecting an MO against *klf2a*, results in dysgenesis of the valve[@b7]. These lines of evidence emphasize that physical stimuli regulate gene expression, but to date, the precise mechanisms remain to be elucidated.

This report has shown that expression of zebrafish *miR-21* is dependent on the heartbeat. Arrest of the heart for 12 h eliminated the expression of both the primary and mature forms of *miR-21* ([Fig. 2](#f2){ref-type="fig"}). More importantly, its expression was restored by a period of heartbeat as short as 1 h ([Fig. 2](#f2){ref-type="fig"}). A similar rapid response was seen in the epinephrine-stimulated head vasculatures ([Fig. 3](#f3){ref-type="fig"}) and HUVECs stimulated by shear stress (see [Supplementary Fig. S2](#S1){ref-type="supplementary-material"}). However, the induction profiles of the *pri-miR-21*, mature *miR-21*, *KLF2* are different in HUVECs, depending on the natures of the applied flows. Endothelial cells are known to respond differently to chaotic and steady flows[@b45][@b46], and the expression of zebrafish *klf2a* is dependent on the reversing flow, reinforcing the importance of the flow during cardiogenesis and physiological adaptation.

In addition, a set of genes can be induced by the flow in a temporally controlled manner, with *miR-21*, *klf2a* and *egr1* as early responders and *miR-143* and *miR-23* as late ones. In this sense, it is particularly important that *miR-23b* and *miR-143/145* can be induced by KLF2 in HUVECs[@b47], and that EGR1 binds to regulatory regions of the *miR-23a/24/27a* cluster and *KLF2* (ref. [@b48]). This indicates that this hierarchical induction contributes to the distinct temporal profiles of gene induction.

Recently, stress-dependent remodelling of cardiac tissues has been shown to occur in the absence of *miR-21* in mouse (T.B. *et al.,* unpublished observation)[@b17][@b36][@b49]. Genetic deletion of *miR-21* protects against tumour formation via modulation of the MAP kinase cascade[@b15] but the valveless phenotype was not found in either *miR-21*-null or antagomir-treated mice[@b15][@b17]. This implies that *miR-21* acts differently in different tissue contexts (cardiomyocytes/cardiac fibroblast in mouse versus valve-forming endocardial cells in zebrafish), yet regulating the same targets. Phenotypic differences are also seen in *Klf2*/*klf2a*. *Klf2*-null mice show abnormal vascular morphology, a loss of vessel wall stability and heart failure[@b44], whereas the *klf2a*-morphants display dysmorphogenesis of the valve[@b7]. The phenotypic discrepancies observed in *miR-21* and *Klf2*/*klf2a* might relate to the fact that valve leaflets arise from the mesenchyme cushion in mice, whereas they are formed by protrusion of the endocardium in zebrafish[@b50]. As cardiomyocytes and mesenchymal cells do not contact the blood stream, they are unable to receive flow stimuli. This spatial separation prevents them from responding to shear stress. Shear stress and stretch activate *miR-21* with different temporal profiles (our unpublished observation), hereby these two stimuli could act differently. In addition, signalling cascades specifically acting on cardiomyocytes, such as BMP, might modify the actions of *miR-21*, as suggested by SMAD-dependent maturation of *miR-21* (ref. [@b51]). We also do not exclude the possibility that myocardial contraction might affect expression of *miR-21* by an unknown mechanism.

In addition to these developmental contexts, the haemodynamic forces may differ between the zebrafish and mouse; for example, the Reynolds number at the valve-forming stage is 0.017 at 26 hpf in zebrafish and 0.205 at 10.5 dpc in the mouse[@b52], implying that viscous shear forces are relatively more important for zebrafish cells.

*miR-21* is also expressed in the OFT and AV valves of adult hearts ([Fig. 1](#f1){ref-type="fig"}). In adult mammals, valves and vascular endothelial cells are susceptible to mechanical injury and pathogenic conditions associated with irregular shear, leading to cell proliferation and expression of genes, including *Egr1* (refs [@b53], [@b54], [@b55]). Accordingly, the expression *miR-21* in the adult valves of zebrafish might be involved in their homoeostatic maintenance.

Recently, it was shown that excessive endocardial cushions were formed in zebrafish *dicer* mutant[@b30], a conflict result with the *miR-21* morphants. However, in the *dicer* mutant, processing of all miRNAs are blocked not only in the endocardium, but also in the myocardium, implying that unknown miRNA(s) might be negatively involved in the formation of endocardial cushions.

We have demonstrated that *miR-21* is a novel component of a mechanotransduction pathway in which blood flow is the primary stimulus for gene expression. This is summarized in [Supplementary Fig. S10](#S1){ref-type="supplementary-material"}. In effect, physical forces act as a 'morphogen' producing a gradient of mechanical strain in tissues. Anisotropic distribution of strains is translated into asymmetric gene expression. Future research will look for factors shuttling between the cytoplasm and nucleus in response to mechanical stresses, that is, potential regulatory factors of *miR-21*. By integrating these lines of investigation, we aim to achieve a better understanding of the physical aspects of cardiogenesis and circulatory homoeostasis and, ultimately, to develop new therapeutic methods for diseases caused by haemodynamic changes.

Methods
=======

Antibodies and reagents
-----------------------

To change the haemodynamics, zebrafish embryos were placed in water containing 10 mM of BDM (2,3-butanedione monoxime: Sigma, B-0753) or 2 mM of epinephrine (Wako) at proper stages. For exposure to U0126 (Merck Ltd), embryos were incubated with 100 μM U0126 in 2% dimethyl sulfoxide from 32 hpf until fixation. In all experiments, embryos treated with the vehicles alone were used as a control. An antibody against pERK1/2 (1:100) was purchased from Cell Signaling Technology. Antibodies against dm-grasp (1:200), GFP (1:500) and zebrafish PCNA (1:100) were from Developmental Studies Hybridoma Bank (DSHB), Sigma and AnaSpec, respectively.

cDNA probes and *in situ* hybridization
---------------------------------------

Zebrafish *in situ* hybridization probes were isolated from complementary DNA (cDNA) templates using standard PCR techniques with appropriate sets of primers. To detect expression of mature *miR-21*, DIG-labelled LNA probes were purchased from Integrated DNA technologies. Both whole mount and section *in situ* hybridization experiments were performed according to the protocol published by Exiqon[@b56][@b57].

Quantitative real-time PCR
--------------------------

Approximately 20 zebrafish whole embryos, 10--15 zebrafish hearts and cultured cells (approximately 1 × 10^5^ HUVECs) were homogenized with MULTI-BEADS SHOCKER (MB901U, Yasui Kikai, Osaka, Japan). Total RNAs were isolated by RNeasy Kit (Qiagen), according to the manufacturer's instructions. Each sample was reverse-transcribed into cDNA by miScript RT Kit (Qiagen) and was subjected to qRT--PCR analysis with miScript SYBR Green PCR Kit (Qiagen). Each experiment was carried out with at least one additional biological and experimental replicate. Results in [Fig. 3](#f3){ref-type="fig"} and [Supplementary Fig. S1--S3](#S1){ref-type="supplementary-material"} are shown as mean fold changes ±s.e.m. qRT--PCR primers shown in [Table 1](#t1){ref-type="table"}.

Immunohistochemistry and cell counting
--------------------------------------

Zebrafish embryonic hearts were isolated in L-15 medium (Gibco) and fixed in 4% paraformaldehyde for overnight at 4 °C (for PCNA detection, 1 h at room temperature). Fixation solution was replaced with PBDT (1% bovine serum albumin (BSA); 0.1% Triton X-100; 1% dimethyl sulfoxide in phosphate buffered saline (PBS)) for 1 h. Fixed hearts were incubated with a primary antibody for overnight at 4 °C, briefly washed with PBDT and subsequently incubated with a second antibody conjugated with Alexa Fluor 488 or 594 and 4\',6-diamidino-2-phenylindole (Sigma). Hearts were imaged using a confocal microscope (Olympus FV1000). In order to count the cell number, cell counter plugin with ImageJ was employed. For myocardial cells counting, the *hspGFF3A* transgenic line, which expresses myocardium-specific GFP signal, was used. *fli1*:GFP transgenic line was used for counting the endocardial cells, as well as the PCNA and/or dm-grasp-positive cells. Error bars express mean ±s.e.m. and statistical significance was determined by a *t*-test (*P*\<0.05). The transgenic zebrafish lines *fli1-EGFP* were kindly provided by Kawahara and colleagues[@b58]. *hspGFF3A* was described previously[@b59].

Injection of morpholino oligonucleotides and mRNAs into zebrafish eggs
----------------------------------------------------------------------

MOs were designed and synthesized by Gene Tools (Philomath, OR). Initially, we made several MOs against *miR-21*. One MO (5′-GCCAACACCAGTCTGATAAGCTA-3′), which was also used by Bakkers and colleagues[@b30], was found to be ineffective, as injection of this MO did not induce any specific abnormality in the heart. Other MOs gave the consistent results. MOs were dissolved in the Danieau solution. Approximately 1 nl of MOs were injected into the yolk at the one-cell stage. Sequences, injection concentration and dose are as follows:

*miR-21-1*, Multiblocking 5′-TGTAACAGCCAACACCAGTCTGATAAGCTAT-3′ (1 mM, 10 ng)

*miR-21-2*, Multiblocking 5′-ACTCAAAGCCAACACCAGTCTGATAAGCTAC-3′ (1 mM, 10 ng)

*miR-21-1, Guide Dicer,* 5′-ACAGCCAACACCAGTCTGATAAGCT-3′ (2 mM, 16 ng)

*miR-21-2, Guide Dicer,* 5′-AAAGCCAACACCAGTCTGATAAGCT-3′ (2 mM, 16 ng)

*spry2 miR-21* target protector, 5′-ACTTCAAACCAGTTTTTGCCAATCC-3′ (2 mM, 16 ng)

scrambled MO, Oligo-25N (2 mM, 16 ng).

Sequences of *klf2a*, 5′-AGCTGAGATGCATGGACCTGTCCAG-3′ (2 mM, 16 ng), *tnnt2*, 5′-CATGTTTGCTCTGATCTGACACGCA-3′ (0.5 mM, 4 ng), *gata1*, 5′-CTGCAAGTGTAGTATTGAAGATGTC-3′ (1 mM, 8 ng), *gata2*, 5′-CATCTACTCACCAGTCTGCGCTTTG-3′ (1 mM, 8 ng), and *tbx2b*, 5′-GAGCGTGGAAAGGGTGGTAAGCCAT-3′ (0.25 mM, 2 ng) were previously described[@b7][@b19][@b22][@b24], respectively. To ensure the efficient knockdown, *miR-21-1* and *miR-21-2* MOs were co-injected after mixing equal amounts of two MOs. The *miR-21* morphants shown in this article are by the *miR-21* multiblocking MO, except for [Fig. 4d](#f4){ref-type="fig"}. For overexpression of *miR-21*, miRNA duplexes were purchased from Integrated DNA Technologies, Inc., and were resuspended in the Danieau buffer to a concentration of 100 μM. The sequences are as follows:

*miR-21* duplex A: 5′- UAGCUUAUCAGACUGGUGUUGGC-3′

*miR-21* duplex B: 5′- GCCAACACCAGUCUGAUAAGCUA-3′.

*In vitro* transcription of EGFP-z-spry2 3′-UTR and mCherry mRNAs were performed with mMESSGAE mMACHINE kit (Applied Biosystems) and these synthesized mRNAs were purified with G-50 Micro Columns (GE Healthcare).

Generation of transgenic zebrafish lines
----------------------------------------

For construction of the *miR-21* expression vector, *pre-miR-21* sequence was amplified by PCR from cDNA template and cloned into pT2KXIGΔin vector[@b60]. The Tol2 transposon-mediated transgenesis was carried out by following the procedure described elsewhere[@b60].

Luciferase assay
----------------

HEK293T cells are transfected with psi-CHECK2 vector (Promega) harbouring *z-miR-21*-binding site and the *z-miR-21/GFP* expression vector (pT2KXIGΔin-miR-21/GFP). miRNA dual luciferase assay was carried out by using the Dual luciferase assay kit (Promega).

Shear stress experiment
-----------------------

HUVECs were cultured with Medium 199 (Invitrogen) containing 20% fetal bovine serum (FBS) (SAFC Biosciences), 10 ng ml^−1^ basic fibroblast growth factor (bFGF) (Austral Biologicals) and 1% penicillin--streptomycin (Invitrogen). For experiments, HUVECs were cultured in a 35-mm plastic dish (Iwaki) pre-coated with 0.1% bovine gelatin (Sigma-Aldrich). The experiments were conducted after the cells reach confluence. For the experiments, medium was replaced with Medium 199 containing 0.5% FBS and 1% penicillin--streptomycin, and HUVECs were incubated for 2 h under static condition. For exposing HUVECs to laminar shear stress, a parallel plate flow-chamber, roller pump (HV-07523-80, Master Flex), two reservoir bottles and silicone tubes were used. One reservoir was open to the atmosphere, and the medium in the flow circuit was equilibrated with 95% air and 5% CO~2~ to maintain pH. For the reciprocating flow experiments, the flow-exposure system consisting of the flow-chamber, a 50-ml syringe (Terumo) mounted on a syringe pump (KDS270, KD Scientific), a reservoir glass tube, and silicone tubes were. The flow-chamber was composed of a cell culture dish, a polycarbonate I/O unit, and a silicone gasket. The systems were maintained at 37 C. The flow channel with a length of 22 mm, a width of 14 mm and a height of 0.4 mm was used for generating shear stress of 2.0 Pa. HUVECs were exposed to laminar flow with a shear stress of 2.0 Pa or reciprocating flow with a shear stress of ±2.0 Pa and a frequency of 0.5 Hz for 15, 30, 45, 60, 120 and 240 min in the flow-chamber.

Shear stress estimation
-----------------------

The *fli1a:GFP*/*gata1:RFP* transgenic zebrafish line was mounted in low-melting agarose and treated with 2 mM epinephrine, and movies of blood circulation were taken before and 45 min after epinephrine stimulation with a high speed video camera (EX-F1, CASIO) (30 fps). Velocity of blood flow (*v*) and vessel diameters were measured by the ImageJ software (15 embryos on average). Velocity of blood flow was estimated from migration speed of three RFP-marked blood cells' centroid in two frames. Average vessel diameter (*a*) was obtained from three different points of GFP marked-vessel endothelial cells. The shear stress (*τ*) is *τ=4μQ/πa*[@b3]. *Q* is the volumetric flow rate and we postulated that *Q* is equal to *v* in this estimation. We assumed that blood viscosity (*μ*) is not altered in the presence of epinephrine. Hence, shear stress ratio of epinephrine treated embryos (*τ*~*45*~) to untreated (*τ*~0~) can be given by *τ*~45~*/τ*~*0*~. Error bars represent mean ±s.e.m. Statistical significance was determined by a *t*-test (*P*\<0.05).
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![Expression patterns of *miR-21*.\
(**a**) Soon after initiation of blood flow (36 hpf), *miR-21* began to be expressed in a subset of the endocardial cells in the AV canal (red arrowhead). A, atrium; V, ventricle. (**b**) At 48 hpf, endocardial expression in the OFT became evident (green arrowhead). Expression at the AV canal was arranged around the canal lumen (red arrowhead). (**c**,**d**) The same expression patterns were maintained at 72 hpf (**c**) and 120 hpf (**e**). (**d**) In sections, *miR-21* expression was detected only in the endocardial cells, not in the myocardial layer. (**f**,**g**) Expression of *miR-21* was detected in the valves of adult fish at the OFT (green arrowheads in **f**) and the AV canal (red arrowheads in **g**). Dotted red lines indicate contours of the valves. Black arrows indicate the direction of blood flow. (**h**) A schematic representation of *miR-21* expression only in specific regions of the endocardium of the OFT and the AV canal (blue lines). Scale bars, 50 μm.](ncomms2978-f1){#f1}

![Effect of heartbeat on expression of *miR-21* in the developing heart tube.\
(**a**,**c**) Normal expression of *miR-21* at the OFT (green arrowhead) and the AV canal (red arrowheads) at 48 (**a**) and 72 hpf (**c**). Dotted lines outline the heart. (**b**,**d**). In the *tnnt2* morphants, expression of *miR-21* was detected neither at 48 (**b**) nor at 72 hpf (**d**). (**e**--**g**) Twelve hours arrest of heartbeat (from 72 to 84 hpf in **e**, and from 60 to 72 hpf in **f**) obliterated the two patches of *miR-21* expression, whereas just 1 h of heartbeat restored the full expression (**g**). (**h**--**m)** *pri-miR-21-1* transcripts were expressed in the same patterns at 72 hpf (whole mount in **h**, and section in **i**). This expression was lost in the *tnnt2* morphant heart (**j**). Expression of *pri-miR-21* disappeared after 12 h cardiac arrest (from 72 to 84 hpf in **k**, and from 60 to 72 hpf in **l**) and 1 h of heartbeat restored it (red arrowhead in **m**). WT, wild type; MO, morphant; BDM, treated with BDM. Scale bars, 50 μm.](ncomms2978-f2){#f2}

![Expression patterns of *pri-miR-21-1,* the primary transcript of *miR-21*.\
Expression of *pri-miR-21-1* in the heart (**a**--**e**) and the head vasculature (**f**--**j**) at 53 hpf. The WT (**a**,**b**,**f** and **g**), *gata1* morphants (**c**,**d**,**h** and **i**) and *tnnt2* morphants (**e**,**j**) were stimulated by epinephrine (Epi) from 51.5 to 53 hpf (**b,d,e,g,i** and **j**). Without Epi stimulation, *pri-miR-21-1* was expressed only in the valve-forming endocardium (**a**), not in the head vasculature (**f**). Elimination of blood cells from the circulation by knocking down *gata1* did not affect the expression (**c**,**h**). After stimulation by Epi, expression of *pri-miR-21-1* became slightly stronger at the AV canal (**b**). (**g**) Expression in the head became evident in the metencephalic artery/middle cerebral vein (yellow arrowheads), the primary head sinus (green arrowheads) and the primordial mid-brain channel (black arrowheads). This ectopic induction was not affected in the *gata1* morphants (**i**), but the absence of heartbeat cancelled it (**j**). (**k**) Relative expression of the mature *miR-21* was measured by qRT--PCR using RNA isolated from the whole bodies. In the WT, Epi induced \~1.7-fold, whereas the induction in the *tnnt2* morphant was minimal. In the *gata1* morphants, *miR-21* was induced at a relatively lower extent than the WT (\~1.4-fold). Scale bars, 50 μm (**a**--**e**), 100 μm (**f**--**j**).](ncomms2978-f3){#f3}

![A valveless *miR-21* morphant.\
(**a**--**d**) Blood flow of the *miR-21* morphants stagnated with pooling of blood cells on the yolk at 48 hpf (red arrowhead in **c**,**d**) (MB, multiblocking MO; GD, Guide Dicer MO). This stagnation was neither present in the WT (**a**) nor embryos injected with a scrambled MO (**b**). Higher magnification views are shown in **e**--**h**, with heart contours indicated by dotted lines. (**i**--**m**) At 72 hpf, thick layers of the GFP-positive endocardial cells were protruded into the AV canal (**i**), with cuboidal thickening cells (yellow arrowheads in **j**). Cell shapes are visualized by Dm-grasp staining (**k**,**l)**. Dm-grasp- and GFP-positive cells are cuboidal, whereas Dm-grasp-negative and GFP-positive cells are squamous (**l**). (**m**) A schematic representation of the endocardial cells, with cells in the valve-forming area shown in yellow, Dm-grasp-positive cells in red lines, negative cells in black lines, respectively. A, atrium, V, ventricle. (**n**--**r**) In the *miR-21* morphants, only a thin layer of endocardial cells was evident with neither thickening nor protrusion into the lumen. (**s**--**w**) When heartbeat was stopped from 24 to 72 hpf by BDM, neither thickening nor protrusion of the endocardium was initiated. The number of the Dm-grasp-positive endocardial cells was reduced. Scale bars, 500 μm (**a**--**d**), 50 μm (**i,j,n,o,s,t**).](ncomms2978-f4){#f4}

![Sequence alignment and expression patterns of selected genes.\
(**a**) Sequence alignment of zebrafish *miR-21*, 3′-UTR of *spry2* and its mutated version is shown, with the seed sequences highlighted in yellow and the complementary nucleotides in red and green. (**b**) The *EGFP-spry2* reporter with the WT *spry2* 3′-UTR gave strong fluorescent signals when the endogenous *miR-21* was blocked by the MO against it (left panel), but failed to show the signals when co-injected with the *miR-21* duplex (middle panel). The *EGFP-spry2* reporter mRNA, in which the seed sequence was mutated, produced strong signals even when co-injected with the *miR-21* duplex (right panel) at 24 hpf. (**c,g**) Expression of the endogenous *spry2* was not observed in the WT at 72 hpf (**c**), whereas it was induced in both the OFT and AV canal in the morphant (green and red arrowheads in **g**, respectively). (**d**--**j**) Other target genes, *pdcd4a* (**d**,**h**), *pdcd4b* (**e**,**i**) and *ptenb* (**f**,**j**) were induced in the morphant (**h**--**j**). Expression of these genes was not observed in the WT (**c**--**f**). Scale bars, 50 μm (**c**--**j**).](ncomms2978-f5){#f5}

![Effects of a gain of function of spry2 and U0126 treatment.\
(**a**--**h**) When the MAP kinase cascade was blocked by injection of a target protection (TP) MO of *spry2* (**b**,**f**) or U0126-treatment (**d**,**h**), hearts (dotted outlines) exhibited incomplete looping (**f**,**h**). Red arrowhead indicates pooling of blood, a sign of stagnation of circulation. The normal looped heart is shown in (**e**). (**i--w**) As observed in the *miR-21* morphants and the arrested hearts, the endocardial cells were single-layered, flattened and stretched in the hearts injected with the TP MO of *spry2* (**n**--**r**) and the U0126-treated embryos (**s**--**w**). Normal thickening of cells observed in the WT (**i**--**m**) was lost, as visualized by *fli1-GFP* reporter and Dm-grasp staining. As illustrated in a schematic representation (**m**, **r** and **w**), the multi-layered cuboidal cells observed in the WT (**m**) was detected neither in the hearts injected with the target protection MO of *spry2* (**r**) or treated by U0126 (**w**). Scale bars, 500 μm (**a**--**d**), 50 μm (**i,j,n,o,s,t**).](ncomms2978-f6){#f6}

![Suppression of MAP kinase signalling in *miR-21* morphants and BDM-treated hearts.\
(**a**--**c**) In the WT beating hearts, a phosphorylated form of Erk1/2 (pErk1/2) was stained in the cuboidal endocardial cells at the AV junction (yellow arrowheads in **a**). The entire endocardial cells were labelled by GFP, which expression was driven by the *fli1* promoter (**b**,**c**). (**d**--**f**) In the *miR-21* morphants, the pErk1/2 staining was week and the cells were flat. (**g**--**i**) When the heartbeat was stopped by BDM, phosphorylation of Erk1/2 was also suppressed, leaving only faint staining in the apical surface of flattened endocardial cells. (**j**--**o**) Injection of the *miR-21* target protection MO and the U0126 treatment gave the same results on pErk1/s staining. A, atrium; V, ventricle. Scale bars, 20 μm.](ncomms2978-f7){#f7}

###### qRT--PCR primers.

  **Forward**                                    **Reverse**
  ---------------------------------------------- ---------------------------------------------
  z-*miR-21* 5′-TAGCTTATCAGACTGGTGTTGGC-3′       h-*pri-miR-21* 5′-AGCAGACAGTCAGGCAGGAT-3′
  h-*miR-21* 5′-TAGCTTATCAGACTGATGTTGA-3′        z-*klf2a* 5′-GAGATGGTCGGACCTGGAGA-3′
  h-*pri-miR-21* 5′-TTTTGTTTTGCTTGGGAGGA-3′      h-*KLF2* 5′-CATGTGCCGTTTCATGTGC-3′
  z-*klf2a* 5′-CACACAGGCGAGAAGCCCTA-3′           z-*egr1* 5′-CCAGGCTGAACAGAGGCTCA-3′
  h-*KLF2* 5′-CAAGACCTACACCAAGAGTTCG-3′          z-*spry2* 5′-TTCCTATGCTCGGGCAGCTC-3′
  z-*egr1* 5′-TCAGACCTACTCCACCCAACG-3′           z-*ptenb* 5′-TCACTCCCTTCTTGTCTCTGGTCC-3′
  z-*spry2* 5′-AGCCTTGGGATGGTCAGGTG-3′           z-*pdcd4a* 5′-CCCCTGTTCATCTGGTCCAA-3′
  z-*ptenb* 5′-GCAGAGTTGCACAGTATCCATTTGA-3′      z-*pdcd4b* 5′- CTTACGGCCCCGACTAGGAC-3′
  z-*pdcd4a* 5′-GGTCTATGAGGCTGTGGTTATGG-3′       z-*notch1b* 5′-CACGTTGTTGGTGGGAGTGA-3′
  z-*pdcd4b* 5′-TCAGATGAGACGGGGCTTTG-3′          z-*has2* 5′-ACCTCACGCTGCTCAGGAAG-3′
  z-*notch1b* 5′-AATCCCCGTGCAGAAATGGT-3′         z-*bmp4* 5′-GTTCGTCCTCTGGGATGCTG-3′
  z-*has2* 5′-TGATTCAGACACCATGCTGGA-3′           z-*versican* 5′-GACTCCTGTAGCCCGAACCA-3′
  z-*bmp4* 5′-CCTGGAGGAGCTGCAGTCAG-3′            z-*ef1 alpha* 5′-CGCAGGAAAGGAAAACAACTTGG-3′
  z-*versican* 5′-TGCGCATTAAGTGGACCAGA-3′        h-*EF1 alpha* 5′-AAGAGTGGGGTGGCAGGTATTAG-3′
  z-*miR-23* 5′-ATCACATTGCCAGGGATTTCCA-3′         
  z-*miR-24* 5′-TGGCTCAGTTCAGCAGGAACAG-3′         
  z-*miR126* 5′-TCGTACCGTGAGTAATAATGC-3′          
  z-*miR-138* 5′-AGCTGGTGTTGTGAATCAGGCC-3′        
  z-*miR-143* 5′-TGAGATGAAGCACTGTAGCTC-3′         
  z-*miR-145* 5′-GTCCAGTTTTCCCAGGAATCCC-3′        
  z-*miR-150* 5′-TCTCCCAATCCTTGTACCAGTG-3′        
  z-*ef1 alpha* 5′-CTGTGGCAACAGGTGCAGTTCTA-3′,    
  h-*EF1 alpha* 5′-TGCGGTTTTTGTCATCAAA-3′         

Results in [Supplementary Fig. S3](#S1){ref-type="supplementary-material"}, [Supplementary Figs. S1--S3](#S1){ref-type="supplementary-material"} and [Supplementary Fig. S7](#S1){ref-type="supplementary-material"} are shown as mean fold changes ±s.e.m.
